From all of us at Snapdragon, season's greetings and best wishes for the new year.
Snapdragon Chemistry
Research Services
Waltham, MA 3,550 followers
The future of chemical manufacturing
About us
Snapdragon Chemistry is led by world-class scientists who have made many of the key advances in continuous flow chemistry over the past decade. We provide sophisticated thought partnership and services that enable our clients to harness the advantages of continuous flow chemistry in order to discover more effective medicines and other advanced organic materials, accelerate development, and optimize manufacturing. Tim Jamison, a Professor at MIT’s chemistry department, and Aaron Beeler, an Assistant Professor at Boston University, co-founded Snapdragon Chemistry based on two key revolutionary beliefs: (1) Continuous flow chemistry should be applied throughout the entire discovery >> development >> manufacturing value chain to gain the technology’s optimal benefits. (2) Companies need a sophisticated partner that provides end-to-end services to help them implement effective continuous flow solutions. That is why our company is scientifically-led with a core ethos of unrelenting focus on delivering impact for our clients.
- Website
-
http://www.snapdragonchemistry.com
External link for Snapdragon Chemistry
- Industry
- Research Services
- Company size
- 11-50 employees
- Headquarters
- Waltham, MA
- Type
- Privately Held
- Founded
- 2014
- Specialties
- continuous flow chemistry / technology, reaction development and optimization, process development and optimization, portfolio optimization analysis, and continuous manufacturing
Locations
-
Primary
Get directions
300 2nd Ave.
Waltham, MA 02451, US
-
Get directions
Employees at Snapdragon Chemistry
-
Tim Jamison
Professor of Chemistry, Entrepreneur
-
Raghavendhar Reddy Kotha
Scientist- Peptides/Oligonucleotides/Synthetic Polymers/Small molecules/Analytical Development
-
Aaron Beeler
Associate Professor of Chemistry
-
Christopher Welch
Executive Director at Indiana Consortium for Analytical Science and Engineering
Updates
-
Did you miss our webinar last month? You can watch the recording and hear from our experts as they discuss innovations in liquid-phase peptide synthesis, peptide crystallization, method development for peptide impurity analysis and more.
Did you know you can view past webinars by #CambrexExperts on-demand? We have spoken on a variety of topics including peptide-based therapeutics, CDMO partnerships and global onshoring trends, continuous flow, and stability storage. Watch Now: https://lnkd.in/gKA5vnJM #CDMO #PharmaWebinar #Peptides #LifeSciences #Partnerships #ContinuousFlow #FlowChemistry #StabilityStorage #StabilityStudies
-
Download our detailed information sheet to learn more about the specific technologies that enable robust and reproducible cGMP manufacturing of these molecules. https://lnkd.in/gbhZQyy8
Cambrex offers innovative capabilities and technology to develop and manufacture synthetic molecules for use in drug substances, medical devices and diagnostic agents. Together with Snapdragon Chemistry we provide comprehensive capabilities to help you develop and manufacture peptides and complex synthetics. Download our detailed information sheet to learn more: https://lnkd.in/gbhZQyy8 #Peptides #ComplexSynthetics
-
Snapdragon Chemistry reposted this
Hello from #TIDESEurope! We are excited to be in Hamburg this week to discuss your most challenging peptide development projects. Stop by Booth 115 to connect with our experts, Eric Fang, Andy Miles, and Seamus White, and discover why we’re a different brand of experts. #Peptides #ConnectWithCambrex
-
-
Snapdragon Chemistry reposted this
At Cambrex and Snapdragon Chemistry, we believe in a science-forward approach to drug development. In practice, that means ensuring that our technical teams take time to innovate and collaborate on their breakthroughs. Last month, we brought together 70 of our experts from across Cambrex's global sites to share their scientific achievements at our inaugural Cambrex Science Day. From Longmont to Liège, Milan to Massachusetts, and Edinburgh to Estonia, knowledge sharing is critical to delivering our science-forward commitment to clients and patients.
-
As part of our continued investments in R&D for complex synthetics, we are excited to announce Snapdragon Chemistry has collaborated with Atinary Technologies to build a fully automated and AI-driven, medium-throughput Solid-Phase Oligonucleotide Synthesizer (SPOS) for the purpose of autonomous multi-objective process optimizations. By integrating Snapdragon's proprietary LabOS™ software platform with Atinary’s SDLabs™ platform, Snapdragon’s process optimization campaign has demonstrated significant improvements across the tested applications, with up to an 18% increase in product yield and a 22% reduction in cost compared to processes previously optimized by an experienced scientist. Read the full release here: https://lnkd.in/eN3YB9QY
This collaboration integrates Atinary’s Self-driving Labs technology with Snapdragon’s state-of-the-art laboratories and process development capabilities to tackle complex challenges in drug development. By using Atinary’s AI platform, Snapdragon’s process optimization campaign has demonstrated significant improvements across the tested applications, with up to an 18% increase in product yield and a 22% reduction in cost compared to processes previously optimized by an experienced scientist. Atinary Technologies, Snapdragon Chemistry, Cambrex Innosuisse Swiss Chemical Society (SCS) Innovaud Biopôle Lausanne BioAlps - Swiss Health Valley swiss made software Solar Impulse Foundation AgFunder Cherubic Ventures #AI #ML #Robotics #AIDriven #HTE #DrugDevelopment #Innovation #Sustainability #SelfDrivingLabs #SDLabs #NoCode
Atinary Technologies Announces Strategic Collaboration with Snapdragon Chemistry, a Cambrex company
Atinary Technologies on LinkedIn
-
We are beyond thrilled to share this news!! Read the full press release here: https://lnkd.in/gJm5_5nr
We are excited to announce that Snapdragon Chemistry, a Cambrex company, has successfully developed a new liquid-phase peptide synthesis (LPPS) technology that utilizes traditional active pharmaceutical ingredient (API) batch reactors and continuous flow, obviating the dependency on specialized, solid-phase reactors. This new LPPS technology materially reduces solvent demand and the need for excess reagents compared to standard solid-state peptide synthesis processes. Read the full press release here: https://lnkd.in/gJm5_5nr #CDMO #Investment #Pharmaceuticals
-
-
#CPHIMilan 2024 is quickly approaching. Both the Snapdragon Chemistry and Cambrex teams are looking forward to meeting you in Milano, Italy! Click the link to schedule a meeting 8-10 October at stand # 5B1: https://lnkd.in/gj28bNA3 #CPHI #AtTheHeartOfPharma #CDMO #Pharma #Manufacturing #PharmaceuticalIndustry
-
-
We are delighted to join our colleagues from Cambrex in Denver next week at the American Chemical Society's National Fall Meeting. Don't miss the opportunity to hear from our #OrganicChemistry and #MedicalChemistry experts. #ACSFall2024
We're thrilled to be part of American Chemical Society's National Fall Meeting in Denver, CO next week. You don't want to miss these sessions: "Addressing Solvent Limitations and Exothermic Character of Nitroarene Reduction by Diboron Reagents" | August 18, 7:00 PM - 9:00 PM; Poster 4105493 “Expanding Scope and Application of Chemoselective Aromatic Nitro Reductions by Tetrahydroxydiboron” | August 18, 7:00 PM - 9:00 PM; Poster 4106042 “Understanding the Drug Development Process, Life Cycle, and Project Team in the Transition from Discovery to Early Chemical Development: The Nuts and Bolts of IND-Enabling Research” | August 18, 7:00 PM - 9:00 PM; Poster 4109668 “Process Development and Kilogram-scale Demonstration of Nitroarene Reduction by Tetrahydroxydiboron” | August 19, 8:00 PM - 10:00 PM; Poster 4106081 “Accelerating Phase-Appropriate Drug Substance (API) Development: A Case Study Review of Strategic Decisions, Pitfalls and Science Behind Early Phase Development” | August 20, 4:35 PM - 5:00 PM Presented by: Aliakbar Mohammadlou, PhD, Amber Rydholm, Ph.D., Amy Taylor, Bradley Rose, Cy Credille, Derek Burnet M.S., Derrick Juengst, James Graham, Kerrick C. Rees, PhD, Kimberly Casalvieri, Matthew Haynes, Morris Dweck, Saeedeh Torabi Kohlbouni, Sara F., Tracy Milburn #ACSFall2024 #CDMO #ConnectWithCambrex
-
-
We're excited to be part of American Chemical Society's National Fall Meeting in Denver, CO next week. Mark your calendar to attend these presentations from our #ContinuousFlow experts: "Continuous Flow as Enabling Technology for Intrinsically Hazardous Chemistry: Diazotization, Azidation, and Click Chemistry with an Explosive Alkyne" | August 19, 2:40 PM – 3:15 PM | Mile High Ballroom 4C | Presented by Adrian Amador, Ph.D., Director of Chemistry "Scalable On-demand Production of Tetrafluoroethylene for Fluoroalkylations in Continuous Flow" | August 21, 7:00 PM - 9:00 PM | Hall A-C | Presented by Evan Hurlow, Ph.D., Scientist, Process R&D #ACSFall2024
-